ATLASAtea Pharmaceuticals (AVIR) earnings date: Nov 11, 2026
Atea Pharmaceuticals (AVIR) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, after the close. Analysts expect EPS of -$0.50.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AVIR
| Last price | $4.07 (-1.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.0% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Atea Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Atea Pharmaceuticals reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Atea Pharmaceuticals. You can switch it off at any time.
Alert me before AVIR reportsFree to start. Creating an account takes under a minute.
Notify me when Atea Pharmaceuticals reports
Track AVIR free Add Atea Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
AVIR earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.50 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +11.6% |
| Average move around a report | ±5.4% (last 4) |
| Sector | Healthcare · Biotechnology |
Atea Pharmaceuticals earnings history: last 4 reports
Atea Pharmaceuticals last reported on Aug 12, 2026: EPS of -$0.41 against an estimate of -$0.56 (+26.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.56 | -$0.41 | +26.8% | Beat | +0.4% |
| Jul 16, 2026 | $1.10 | $1.17 | +6.4% | Beat | +0.2% |
| Apr 30, 2026 | $2.03 | $2.68 | +32.0% | Beat | +2.8% |
| Mar 5, 2026 | -$0.48 | -$0.57 | -18.8% | Miss | +18.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AVIR
See the fair value, the probability range and the earnings history of Atea Pharmaceuticals on its ATLAS page.
Atea Pharmaceuticals (AVIR) stock analysisPlans from €3.99 a month.
Atea Pharmaceuticals earnings: frequently asked questions
When does Atea Pharmaceuticals (AVIR) report earnings?
Atea Pharmaceuticals is scheduled to report on Wednesday, November 11, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AVIR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.50 per share (USD). Estimates can change before the report.
How often does AVIR beat earnings estimates?
Of its last 4 reports with a recorded result, Atea Pharmaceuticals beat the EPS estimate 3 times; the average surprise was +11.6%. Past results do not predict the next one.
How much does AVIR move around earnings?
Over its last 4 reports the stock moved an average of 5.4% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Atea Pharmaceuticals beat earnings estimates last quarter?
Atea Pharmaceuticals last reported on Aug 12, 2026: EPS of -$0.41 against an estimate of -$0.56 (+26.8% surprise), a beat.
How much does AVIR usually move in a day?
On a normal trading day the ATLAS model puts AVIR’s one-day range at about ±3.0%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer